News
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
December 15
Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients,...
-
December 02– New Assigned Rate Further Validates the Commercial Value of the PreTRM® Test –
Salt Lake City – Dec 2, 2021 – Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker...
-
December 01Results confirmed that a U.S. validated proteomics predictor could be applied in low and middle income countries to help address global preterm birth challenges
Salt Lake City, – December 1, 2021 – Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...
-
November 30– Highly respected healthcare and financial leader joins Sera in its quest to improve pregnancy outcomes of mothers and babies –
Salt Lake City, Nov. 30, 2021 (PR NEWSWIRE) — Sera PrognosticsInc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...
-
November 09
Salt Lake City – November 9, 2021 – Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker...
-
November 08Noted healthcare and technology executive joins to help Sera achieve its vision as The Pregnancy Company® to improve maternal and newborn health
Salt Lake City, Nov. 8, 2021 (PR NEWSWIRE) — Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...
-
November 04– Dr. Myers to support Sera’s commitment to reduce healthcare disparities among underserved communities –
Salt Lake City, Nov. 4, 2021 (PR NEWSWIRE) —Sera Prognostics Inc., The Pregnancy Company™ (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...
-
November 03Publication illustrates the power of stratifying PreTRM® testing risk at or above a threshold of twice the average population risk of spontaneous preterm birth (sPTB).
Salt Lake City – November 3, 2021 – Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker...
-
November 02Partnership to include distribution of a children’s book with essential prenatal healthcare information and support in the form of pregnancy/NICU “care boxes”
Salt Lake City, Nov. 2, 2021 (PR NEWSWIRE) —Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...
-
October 27
Salt Lake City, Oct. 27, 2021 (PR NEWSWIRE) —Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...
Sign up for our investor relations email list here.